Literature DB >> 23832964

Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study.

Yung-Chang Yen1, Shih-Feng Weng, Horng-An Chen, Yung-Song Lin.   

Abstract

BACKGROUND/AIMS: To investigate the risk of developing retinal vein occlusion (RVO) in patients with systemic lupus erythematosus (SLE).
METHODS: In this retrospective population-based cohort study, 6756 patients with SLE and 40 536 controls without SLE (1:6) were selected from the Taiwan National Health Insurance Research Database claims from 2001 to 2006.
RESULTS: The incidence of RVO was 3.46-times higher in the SLE group than in controls (5.61 vs 1.62 per 10 000 person-years) (adjusted HR=3.883, 95% CI 2.299 to 6.558) calculated using Cox proportional hazard regression. Age was an independent risk factor for RVO, with adjusted HRs of 4.842 for individuals aged ≥50 years compared with those 0-49 years. For each age subgroup, the risk of RVO was significantly higher only in the 0-49-year-old SLE group than in controls. In the 0-49-year-old SLE group the incidence of developing RVO was 7.92 times higher (95% CI 3.60 to 17.45) in the SLE group than in the 0-49-year-old controls. In women with SLE, the incidence of developing RVO was 3.33-times higher (95% CI 1.88 to 5.90) than in female controls.
CONCLUSIONS: SLE was significantly associated with an increased risk of developing RVO.

Entities:  

Keywords:  Epidemiology; Retina

Mesh:

Year:  2013        PMID: 23832964     DOI: 10.1136/bjophthalmol-2013-303265

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

Review 1.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

2.  Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET).

Authors:  Francesco Paciullo; Emanuele Valeriani; Angelo Porfidia; Marcello Di Nisio; Marco P Donadini; Rossella Marcucci; Domenico Prisco; Carlo Cagini; Paolo Gresele; Walter Ageno
Journal:  Blood Transfus       Date:  2022-01-21       Impact factor: 5.752

Review 3.  Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?

Authors:  Ashish N Rao; Nayef M Kazzaz; Jason S Knight
Journal:  World J Cardiol       Date:  2015-12-26

4.  Evaluation of subclinical retinopathy and angiopathy with OCT and OCTA in patients with systemic lupus erythematosus.

Authors:  Mehmed Uğur Işık; Berkay Akmaz; Fahrettin Akay; Yusuf Ziya Güven; Dilek Solmaz; Önay Gercik; Gökhan Kabadayı; İdil Kurut; Servet Akar
Journal:  Int Ophthalmol       Date:  2020-08-26       Impact factor: 2.031

5.  Systemic lupus erythematosus and thrombosis.

Authors:  Mario Bazzan; Antonella Vaccarino; Fabio Marletto
Journal:  Thromb J       Date:  2015-04-23

6.  Retinopathy in lupus transitioned to Kikuchi-Fujimoto disease.

Authors:  Kelly S Rue; Damien C Rodger; Narsing A Rao
Journal:  Am J Ophthalmol Case Rep       Date:  2016-06-15

7.  Systemic abnormalities associated with retinal vein occlusion in young patients.

Authors:  Suthasinee Sinawat; Chavisa Bunyavee; Tanapat Ratanapakorn; Supat Sinawat; Wipada Laovirojjanakul; Yosanan Yospaiboon
Journal:  Clin Ophthalmol       Date:  2017-02-23

8.  Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age.

Authors:  Maurizio Battaglia Parodi; Francesco Romano; Alessandro Arrigo; Stefano Mercuri; Alessandro Franceschi; Francesco Bandello
Journal:  Biomed Res Int       Date:  2020-06-17       Impact factor: 3.411

9.  Gallstone is correlated with an increased risk of idiopathic sudden sensorineural hearing loss: a retrospective cohort study.

Authors:  Chong-Chi Chiu; Kuan-Ji Lee; Shih-Feng Weng; Yuan-Ming Yang; Yung-Song Lin
Journal:  BMJ Open       Date:  2015-09-29       Impact factor: 2.692

Review 10.  Ischemic retinal vasculitis and its management.

Authors:  Lazha Talat; Sue Lightman; Oren Tomkins-Netzer
Journal:  J Ophthalmol       Date:  2014-04-15       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.